Pediatric and Developmental Neurology
- Neurological Disorders in Children
- Genetic Disorders and Pediatric Neurology
- Neonatal Neurological Care
- Neonatal Brain Injury and Hypoxic-Ischemic Encephalopathy
- Pediatric Epilepsy and Seizure Management
- Pediatric Stroke and Neurovascular Disorders
- Cerebral Palsy and Neurodevelopmental Delays
- Congenital Brain Malformations
- Cognitive and Behavioral Aspects of Pediatric Neurology
Pediatric and Developmental Neurology focuses on the diagnosis, treatment, and management of neurological disorders affecting infants, children, and adolescents. This session will explore the latest advancements in understanding neurodevelopmental conditions, including autism spectrum disorder (ASD), attention-deficit hyperactivity disorder (ADHD), cerebral palsy, epilepsy, muscular dystrophies, genetic neurological syndromes, and metabolic brain disorders. Discussions will highlight early diagnosis, neuroimaging, genetic testing, and the role of biomarkers in detecting neurological conditions at an early stage, enabling timely intervention and personalized treatment strategies.
A key focus will be on therapeutic approaches such as gene therapy, neurorehabilitation, brain stimulation techniques, targeted pharmacological treatments, and behavioral interventions aimed at improving cognitive, motor, and social development. Special emphasis will be given to the role of neuroplasticity in pediatric brain development, as well as emerging technologies like artificial intelligence (AI), robotics-assisted therapy, and precision medicine in advancing pediatric neurological care. Additionally, the session will address challenges in managing pediatric epilepsy, neuroimmune disorders, leukodystrophies, and rare genetic disorders, providing a comprehensive understanding of current clinical and research perspectives.
By bringing together pediatric neurologists, neuroscientists, geneticists, and healthcare professionals, this session aims to enhance collaborative efforts in advancing research, developing novel therapies, and improving long-term outcomes for children with neurological and developmental disorders.
